SCHEMBL6369014

SCHEMBL6369014

C1=CC=CNc2ccccc2C=NC=CC=CC=CN=Cc2ccccc2N=CC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6369137 1.00
SCHEMBL6369005 1.00
SCHEMBL6369008 1.00
SCHEMBL6369140 1.00
SCHEMBL6369143 1.00
SCHEMBL7336235 0.78 TRPA1 (0.35)
SCHEMBL7336245 0.78 TRPA1 (0.35)
SCHEMBL211612 0.75 GAA (0.36)
Hydrochloric Acid SCHEMBL2360762 0.73 GAA (0.34)
Hydrochloric Acid SCHEMBL3772181 0.73 GAA (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009733-A1 Compositions of a cyclooxygenase-2 selective inhibitor and a potassium ion channel modulator for the treatment of central nervous system damage PHARMACIA CORPORATION 2005-01-13 US disclosed